Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-01T07:01:06.331Z Has data issue: false hasContentIssue false

Experiences with the Execution of Intercultural, Intercontinental Trials - Part I

Published online by Cambridge University Press:  23 September 2014

Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Large scale, international clinical trials are formidable challenges, but they are the most effective means of answering important clinical questions in a definitive, generalizable manner. They require adequate funding and must be rigorously conducted. Much can be gleaned from such studies, which address the important research questions and provide answers to related questions. Such trials are enormously rewarding and are worth the expense and effort.

Résumé:

Résumé:

Les essais cliniques internationaux à grande échelle présentent des défis formidables, mais ils constituent le moyen le plus efficace de répondre de manière généralisable et définitive à des questions importantes au point de vue clinique. Ils doivent être financés adéquatement et doivent être menés rigoureusement. Beaucoup d'information peut être recueillie de ces études qui répondent à la question principale et fournissent des réponses à des questions connexes. Ces essais cliniques fournissent des renseignements très utiles et justifient les dépenses et l'effort qu'elles requièrent.

Type
Historical Review
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Barnett, HJM. Personal reflections from a front-row seat at the greatest show on earth (life); part II (stroke research commentary). Stroke. 2009;40:e5365.Google Scholar
2. NASCET Collaborators: Beneficial affect of endarterectomy in symptomatic patients with high-grade carotid stenosis. N Eng J Med. 1991;325:445–53.Google Scholar
3. Fox, AJ, Eliasziw, M, Rothwell, PM, Schmidt, MH, Warlow, CP, Barnett, HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and European Carotid Surgery Trial (ECST) Group. Identification, prognosis, and management of patients with carotid artery near occlusion. AJNR Am J Neuroradiol. 2005;26(8):2086–93.Google Scholar
4. Barnett, HJM, Peerless, SJ, Kaufmann, JCE. “Stump” of internal carotid artery - a source for further cerebral embolic ischemia. Stroke. 1978;9(5):448–56.Google Scholar
5. The Canadian Cooperative Stroke Study Group (1978). A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299(2):53–9.Google Scholar
6. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348(9038):1329–39.Google Scholar
7. Diener, HC, Bogousslavsky, J, Brass, LM, et al. Aspirin compared with clopidogrel alone after recent ischaemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331–7.CrossRefGoogle ScholarPubMed
8. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Eng J Med. 1985;313(19):1191–200.Google Scholar
9. Barnett, HJM, Taylor, DW, Eliasziw, M, et al for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339 (20):1415–25.Google Scholar
10. Taylor, DW, Barnett, HJM, Haynes, RB, et al for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial. Lancet. 1999;353(9171):2179–84.Google Scholar